We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Research · September 25, 2022

Efficacy and Safety of Basal Insulin + Two to Three Oral Antihyperglycaemic Drugs vs Twice-Daily Premixed Insulin + Metformin After Short-Term Intensive Insulin Therapy in Type 2 Diabetes

Diabetes, Obesity & Metabolism


Additional Info

Diabetes, Obesity & Metabolism
Efficacy and safety of a basal insulin + 2-3 oral antihyperglycaemic drugs regimen versus a twice-daily premixed insulin + metformin regimen after short-term intensive insulin therapy in individuals with type 2 diabetes: The multicentre, open-label, randomized controlled BEYOND-V trial
Diabetes Obes Metab 2022 Oct 01;24(10)1957-1966, Q Pan, Y Li, H Wan, J Wang, B Xu, G Wang, C Jiang, L Liang, W Feng, J Liu, T Wang, X Zhang, N Cui, Y Mu, L Guo

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading